JPRN-UMIN000032529
Recruiting
未知
The analysis of renal complication associated with Rheumatoid Arthritis - The analysis of renal complication associated with Rheumatoid Arthritis
ConditionsRheumatoid Arhtritis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Rheumatoid Arhtritis
- Sponsor
- Toranomon hospital
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patients with other rheumatologic or autoimmune disease.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Renal complications of Amikacin in patients with neonatal sepsisIRCT20201212049686N1Tehran University of Medical Sciences90
Not yet recruiting
Not Applicable
A study of kidney Problems with covid 19 in admitted patients at a teritiary care hospital.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 3: B338- Other specified viral diseasesCTRI/2020/12/029581nil
Completed
Not Applicable
Influence of renal dysfunction on the outcomes of hepatectomy for hepatocellular carcinomaJPRN-UMIN000041749Hiroshima University238
Active, not recruiting
Not Applicable
Evaluation of the possible renal impairment following iodium containing solutions administration in radiographyEUCTR2012-004742-16-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
Active, not recruiting
Phase 1
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2014-005033-31-FRAddmedica S.A.S